Overview
Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use . Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system . Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.
Background
Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use . Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system . Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.
Indication
Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insomnia, pruritis, urticaria, insect bites/stings, allergic rashes, and nausea . Additionally, when the use of oral diphenhydramine is impractical, there are also prescription-only formulations such as diphenhydramine injection products that are effective in adults and pediatric patients (other than premature infants and neonates) for: i) the amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after acute allergic reaction symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated ; ii) the active treatment of motion sickness ; and iii) use in parkinsonism when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents .
Associated Conditions
- Allergic Reaction
- Allergic Rhinitis (AR)
- Allergic cough
- Allergy to Tree Pollen
- Anaphylaxis
- Angioedema
- Common Cold
- Conjunctival irritation
- Cough
- Cough Variant Asthma
- Cough caused by Common Cold
- Eye allergy
- Fever
- Insect Bites
- Insect Stings
- Insomnia
- Irritative cough
- Itching of the nose
- Itching of the throat
- Motion Sickness
- Nasal Congestion
- Oral Mucositis
- Pain
- Parkinsonian Syndromes
- Productive cough
- Pruritus
- Rash
- Rhinorrhoea
- Sinus Congestion
- Sinus headache
- Skin Irritation
- Sneezing
- Sunburn
- Symptoms of Acute Bronchitis Accompanied by Coughing
- Upper respiratory tract hypersensitivity reaction, site unspecified
- Urticaria
- Cold or flu syndrome
- Dermatographism
- Dry cough
- Watery itchy eyes
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/04/04 | Phase 3 | Not yet recruiting | |||
2024/11/26 | Phase 3 | Not yet recruiting | |||
2024/11/25 | Phase 2 | Not yet recruiting | |||
2024/04/10 | Phase 2 | Recruiting | |||
2024/04/03 | Not Applicable | ENROLLING_BY_INVITATION | |||
2024/03/15 | Phase 4 | Completed | |||
2024/01/22 | Phase 4 | Recruiting | |||
2024/01/16 | Phase 1 | Recruiting | |||
2023/12/26 | Not Applicable | Recruiting | |||
2023/10/16 | Phase 2 | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Wal-Mart Stores Inc | 49035-164 | ORAL | 25 mg in 1 1 | 5/28/2025 | |
P & L Development, LLC | 49580-0314 | ORAL | 50 mg in 30 mL | 3/24/2025 | |
HF Acquisition Co LLC, DBA HealthFirst | 51662-1218 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 2/19/2020 | |
REMEDYREPACK INC. | 70518-3685 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 4/2/2024 | |
Softgel Healthcare Pvt Ltd | 35916-0472 | ORAL | 50 mg in 1 1 | 4/8/2025 | |
Cardinal Health 110, LLC. DBA Leader | 70000-0701 | ORAL | 12.5 mg in 5 mL | 4/28/2025 | |
Fresenius Kabi USA, LLC | 63323-664 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 10/3/2019 | |
Whole Foods Market, INC. | 42681-0051 | ORAL | 50 mg in 1 1 | 5/21/2025 | |
Belleview Bioscience LLC | 84447-128 | ORAL | 12.5 mg in 5 mL | 6/17/2025 | |
State of Florida DOH Central Pharmacy | 53808-0238 | ORAL | 50 mg in 1 1 | 5/25/2010 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
BENOCTEN TABLET 50 mg | SIN00362P | TABLET | 50 mg | 4/23/1988 | |
PAXIDORM TABLETS 25 mg | SIN10851P | TABLET, SUGAR COATED | 25 mg | 4/1/1999 | |
PHENEXPECT SYRUP | SIN09014P | SYRUP | 12.5 mg/5 ml | 11/28/1996 | |
DIPHEN 10 EXPECTORANT | SIN08799P | SYRUP | 10 mg/5 ml | 7/3/1996 | |
SUNTUSS SYRUP | SIN03491P | SYRUP | 10 mg/5 ml | 6/24/1989 | |
UNIDRYL CD EXPECTORANT | SIN02917P | SYRUP | 14mg/5ml | 5/22/1989 | |
HOVA EXPECTORANT | SIN03251P | SYRUP | 14 mg/5 ml | 6/12/1989 | |
DIPRODIN ELIXIR | SIN07830P | ELIXIR | 12.5 mg/5 ml | 9/1/1994 | |
DIPRODIN ELIXIR | SIN07830P | ELIXIR | 12.5 mg/5 ml | 9/1/1994 | |
SW-BENA PAEDIATRIC EXPECTORANT | SIN07609P | SYRUP | 5 mg/5 ml | 1/14/1994 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Diphenhydramine Hydrochloride Softgels | 国药准字H20070315 | 化学药品 | 胶囊剂 | 3/2/2022 | |
Diphenhydramine Hydrochloride Softgels | 国药准字H20070314 | 化学药品 | 胶囊剂 | 3/2/2022 | |
Diphenhydramine Hydrochloride Injection | 国药准字H32021847 | 化学药品 | 注射剂 | 5/11/2020 | |
Diphenhydramine Hydrochloride Injection | 国药准字H61021679 | 化学药品 | 注射剂 | 4/20/2023 | |
Diphenhydramine Hydrochloride Injection | 国药准字H20053926 | 化学药品 | 注射剂 | 10/18/2023 | |
Diphenhydramine Hydrochloride Injection | 国药准字H42020696 | 化学药品 | 注射剂 | 1/3/2023 | |
Diphenhydramine Hydrochloride Injection | 国药准字H35020106 | 化学药品 | 注射剂 | 2/28/2020 | |
Diphenhydramine Hydrochloride Injection | 国药准字H42021175 | 化学药品 | 注射剂 | 7/13/2020 | |
Diphenhydramine Hydrochloride Injection | 国药准字H32021435 | 化学药品 | 注射剂 | 8/11/2020 | |
Diphenhydramine Hydrochloride Injection | 国药准字H41020225 | 化学药品 | 注射剂 | 2/24/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
BACAMINE LOTION | N/A | N/A | N/A | 3/25/1982 | |
LONGAXON CREAM | N/A | unicorn laboratories o/b american unicorn laboratories limited | N/A | N/A | 1/14/1997 |
CALAMINE-D LOTION | N/A | N/A | N/A | 7/3/1979 | |
AICADRYL LOTION | N/A | N/A | N/A | 9/30/1981 | |
RAPIDERM CREAM | N/A | unicorn laboratories o/b american unicorn laboratories limited | N/A | N/A | 8/23/1999 |
CALAMINE WITH D.P.H CREAM | N/A | N/A | N/A | 12/10/1983 | |
TRIDAZINE-FORTE CREAM | N/A | N/A | N/A | 9/28/2009 | |
LAMEBA CREAM | N/A | N/A | N/A | 3/21/2000 | |
F-HANSONE CREAM | N/A | frankin pharmaceutical laboratories co ltd | N/A | N/A | 12/14/1998 |
CALOX CREAM | N/A | N/A | N/A | 2/22/1980 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
PHARMACY CHOICE NIGHT PAIN RELIEF film-coated tablet blister pack | 294150 | Medicine | A | 9/20/2017 | |
SNUZAID TABS diphenhydramine hydrochloride 50mg tablet blister pack | 129483 | H W Woods Pty Ltd | Medicine | A | 7/14/2006 |
PRICELINE PHARMACY NIGHT PAIN RELIEF tablet blister pack | 450607 | Medicine | A | 6/3/2024 | |
MERSYNONIGHT NIGHT TIME PAIN RELIEF tablet blister pack | 301428 | Medicine | A | 3/29/2018 | |
BENADRYL COUGH MEDICINE FOR DRY COUGHS oral liquid bottle (reformulation) | 57233 | Medicine | A | 11/27/1996 | |
PANADOL NIGHT capsule-shaped tablet blister pack (reformulation) | 167596 | Medicine | A | 12/16/2009 | |
PHARMACY HEALTH NIGHT PAIN RELIEF tablet blister pack | 450606 | Medicine | A | 6/3/2024 | |
COMBOLIEVE NIGHT PAIN RELIEF paracetamol 500 mg and diphenhydramine hydrochloride 25 mg tablet blister pack | 373152 | Medicine | A | 8/19/2021 | |
VIDALIFE NIGHT PAIN tablet blister pack | 356972 | Medicine | A | 3/18/2021 | |
NEOCOMBO DAY & NIGHT PAIN RELIEF tablet blister pack | 371305 | Medicine | A | 7/19/2021 |